PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 23, 2025BMC Infectious Diseases2 citationsOpen Access

Development and validation of a nomogram for predicting PICC catheter-related bloodstream infection among patients with hematologic malignancies

View Full Paper
QGQian GuoYLYuting LiuXZXiaoli Zhu

Key Points

  • PICC-related bloodstream infections occurred in 6.02% of patients with hematologic malignancies.
  • Key risk factors included diabetes, age, and catheter characteristics, as identified through multiple regression analysis.
  • A predictive nomogram was developed using LASSO regression methods, achieving AUC values of 0.883 and 0.822 in validation.
  • This tool supports risk stratification and may guide targeted prevention efforts for infections in hematologic patients.

Abstract

To identify risk factors for PICC-related bloodstream infections (PICC-CRBSI) in patients with hematologic malignancies and to develop and validate a predictive nomogram for clinical risk assessment. This retrospective cohort study included 764 patients with hematologic malignancy who had PICC from a tertiary center (2021–2024). LASSO regression identified key predictors after addressing class imbalance via SMOTE-NC in the training set (n = 534). A multivariate logistic regression was used to construct a predictive nomogram, subsequently validated in a validation set (n = 230). Model performance was assessed by area under the receiver operating characteristic curve (AUC), calibration curves with bootstrap resampling, and decision curve analysis (DCA). In our cohort, the occurrence of PICC-CRBSI infections was 6.02% (46/764) and Gram-negative bacteria was the major causative pathogen. Multivariate regression analysis showed that History of diabetes, Age, Time of PICC placement, PICC insertion attempts, Catheterized Diameter, Catheterized vein, ANC, ALC and D-dimer were independent risk factors associated with PICC-CRBSI in hematologic malignancy patients. Our nomogram model demonstrated a good calibration and discrimination in both training and validation sets, with AUC values of 0.883 and 0.822, The DCA suggested potential clinical utility. This validated nomogram integrates patient, catheter, and biomarker-specific factors to individualize PICC-CRBSI risk stratification in hematologic malignancies, potentially guiding targeted prevention strategies.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Guo et al. (2025) studied this question.

synapsesocial.com/papers/68fa32a40df2e6cd2f741ff0https://doi.org/10.1186/s12879-025-11815-4
Ask AI
Helpful
Bookmark
Share
View Full Paper